Treace Medical Concepts, Inc. TMCI EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Treace Medical Concepts, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Treace Medical Concepts, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Treace Medical Concepts, Inc.'s EPS (diluted)?
- Treace Medical Concepts, Inc. (TMCI) reported EPS (diluted) of -$0.28 in Q1 2026.
- How has Treace Medical Concepts, Inc.'s EPS (diluted) changed year-over-year?
- Treace Medical Concepts, Inc.'s EPS (diluted) decreased by 12.0% year-over-year, from -$0.25 to -$0.28.
- What is the long-term trend for Treace Medical Concepts, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s EPS (diluted) has grown at a 22.0% compound annual growth rate (CAGR), from -$0.42 to -$0.93.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.